Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011671 |
---|---|
Receipt number | R000013646 |
Scientific Title | Phase I/II study eribulin mesylate and lapatinib for metastatic in patients with human epidermal growth factor receptor 2-positive breast cancer previously treated with an anthracycline, taxane and trastuzumab |
Date of disclosure of the study information | 2013/09/06 |
Last modified on | 2013/09/06 16:52:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/09/06 16:53:00 |